RxDoctor Payments Data

Nicholas Monsul, MD

Plastic Surgery Within the Head and Neck · Sarasota, FLNPI 1154325439

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,150 of the $5,342 with a category attached, or 96.4%. Specialty Surgical Instrumentation accounts for 96.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $3,162 and has fallen 99.5% since, to $16 in 2023.

$5,342in general payments, 2019–2025

Across 17 payments — averaging $314.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Specialty Surgical Instrumentation$5K
  • Tersera Therapeutics LLC$39
  • Pharming Healthcare, Inc.$30
  • Amgen$27
  • Sanofi$24
  • Alk-abello, Inc$21
  • plus $51 from 3 others

What the payments were for

  • Consulting fees$5,15096%
  • Food & beverage$1924%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Specialty Surgical Instrumentation7$5,150
Tersera Therapeutics LLC2$39
Pharming Healthcare, Inc.2$30
Amgen1$27
Sanofi1$24
Alk-abello, Inc1$21
Merz North America, Inc.1$21
Aimmune Therapeutics, Inc.1$18
Kaleo, Inc.1$12

How this compares

$5,342 in reported general payments places this provider in the 80th percentile of 50 plastic surgery within the head and neck providers in Florida.

See all plastic surgery within the head and neck providers in Florida

Medicare billing

Part B allowed, 2024
$543,556
Medicare patients
156
Services billed
3,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$309

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head and neck in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →